Clicca qui per scaricare

La pandemia silenziosa dei disturbi del neurosviluppo
Titolo Rivista: PNEI REVIEW 
Autori/Curatori: Ernesto Burgio, Cristina Panisi 
Anno di pubblicazione:  2017 Fascicolo: Lingua: Italiano 
Numero pagine:  16 P. 17-32 Dimensione file:  1125 KB
DOI:  10.3280/PNEI2017-001003
Il DOI è il codice a barre della proprietà intellettuale: per saperne di più:  clicca qui   qui 


Nel novembre 2006 un articolo su The Lancet a fi rma di un pediatra e di un epidemiologo della Harvard School of Pubblic Health poneva con forza il problema di una "pandemia silenziosa" di danni neuro-psichici che si starebbero diffondendo, nell’indifferenza generale, in tutto il Nord del pianeta. All’origine del drammatico incremento di disturbi del neurosviluppo (in particolare dello spettro autistico) e di patologie neuropsichiatriche sarebbero condizioni materno-fetali di "stress" persistente, infi ammazione/infezione cronica, esposizione a migliaia di molecole di sintesi, potenzialmente neuro-tossiche (pesticidi, metalli pesanti e perturbatori endocrini), presenti in placenta, sangue cordonale e latte materno. Nei successivi 10 anni i dati epidemiologici e tossicologici che confermano la tesi dei due autori si sono andati accumulando.


Keywords: Transizione epidemiologica del 20°-21° secolo, Pandemia silenziosa, teoria DOHaD

  1. Aldad TS, Gan G, Gao XB, et al. (2012) Fetal Radiofrequency Radiation Exposure From 800-1900 Mhz-Rated Cellular Telephones Affects Neurodevelopment and Behavior in Mice, Sci Rep 2:312. doi.org/10.1038/srep00312
  2. Aldinger KA, Lane CJ, Veenstra-VanderWeele J, et al. (2015) Patterns of Risk for Multiple Co-Occurring Medical Conditions Replicate Across Distinct Cohorts of Children with Autism Spectrum Disorder, Autism Res 8(6):771-781. doi.org/10.1002/aur.1492
  3. Anholt GE, Cath DC, van Oppen P, et al. (2010) Autism and ADHD symptoms in patients with OCD: are they associated with specifi c OC symptom dimensions or OC symptom severity?, J Autism Dev Disord 40(5):580-589. doi.org/10.1007/s10803-009-0922-1
  4. Ashwood P, Corbett BA, Kantor A, et al. (2011) In search of cellular immunophenotypes in the blood of children with autism, PLoS One 6:e19299. doi.org/10.1371/journal.pone.0019299
  5. Atladóttir HO, Pedersen MG, Thorsen P, et al. (2009) Association of family history of autoimmune diseases and autism spectrum disorders, Pediatrics 124(2):687-694. doi.org/10.1542/peds.2008-2445
  6. Atladóttir HO, Thorsen P, Østergaard L, et al. (2010) Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders, J Autism Dev Disord 40(12):1423-1430. doi.org/10.1007/s10803-010-1006-y
  7. Atladóttir HO, Henriksen TB, Schendel DE, et al. (2012) Autism after infection, febrile episodes, and antibiotic use during pregnancy: An exploratory study, Pediatrics 130(6):e1447-e1454. doi.org/10.1542/peds.2012-1107
  8. Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases, N Engl J Med 347(12): 911-20. doi.org/10.1056/NEJMra020100
  9. Bilbo SD e Schwarz JM (2012) The immune system and developmental programming of brain and behavior, Front Neuroendocrinol 33(3):267-286. doi.org/10.1016/j.yfrne.2012.08.006
  10. Blank M e Goodman R (2009) Electromagnetic fi elds stress living cells, Pathophysiol 16(2-3):71-78. doi.org/10.1016/j.pathophys.2009.01.006
  11. Blaxill MF (2004) What’s going on? The question of time trends in autism, Public Health Rep 119(6):536-551. doi.org/10.1016/j.phr.2004.09.003
  12. Bolte ER (1998) Autism and Clostridium tetani, Med Hypotheses 51:133-144. doi.org/10.1016/S0306-9877(98)90107-4
  13. Brannen KC, Devaud LL, Liu J, et al. (1998) Prenatal exposure to neurotoxicants dieldrin or lindane alters tert-butylbicyclophosphorothionate binding to GABA(A) receptors in fetal rat brainstem, Dev Neurosci 20(1):34-41. doi.org/10.1159/000017296
  14. Brookmeyer R, Johnson E, Ziegler-Graham K, et al. (2007) Forecasting the global burden of Alzheimer’s disease, Alzheimers Dement 3(3):186-91. doi.org/10.1016/j.jalz.2007.04.381
  15. Bouchard MF, Bellinger DC, Wright RO, et al. (2010) Attention-defi cit/hyperactivity disorder and urinary metabolites of organophosphate pesticides, Pediatrics 125(6):e1270-e1277. doi.org/10.1542/peds.2009-3058
  16. Burgio E (2011) Il problema dell’incremento dei tumori infantili. Cancerogenesi transplacentare e transgenerazionale, in: Ridolfi R (a cura di) 2011, Progetto Ambiente e Tumori, AIOM, pp. 51-61.
  17. Burgio E (2013a) Notes on the epigenetic origins of childhood cancer, Epidemiol Prev 37(1 Suppl 1):261-265.
  18. Burgio E (2013b) Capitolo 7 Verso un nuovo “Paradigma”: Epigenetica e Rivoluzione Epidemiologica del XX Secolo (PARTE B), in: Burgio E 2013, Ambiente e Salute. Inquinamento, interferenze sul genoma umano e rischi per la salute, CG Edizioni Medico Scientifi che, Torino, pp. 61-67.
  19. Burgio E, Lopomo A e Migliore L (2015a) Obesity and diabetes: from genetics to epigenetics, Mol Biol Rep 42(4):799-818. doi.org/10.1007/s11033-014-3751-z
  20. Burgio E (2015b) Environment and Fetal Programming: the origins of some current “pandemics”, J Pediatr Neonat Individual Med 4(2):e040237. doi.org/10.7363/040237
  21. Centers for Disease Control and Prevention (2007) Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002, MMWR Surveill Summ 56(SS1):12-28.
  22. Centers for Disease Control and Prevention (2012) Prevalence of autism spectrum disorder - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008, MMWR Surveill Summ 61(SS03):1-19.
  23. Chen C, MA Q, Liu C, et al. (2014) Exposure to 1800 MHz radiofrequency radiation impairs neurite outgrowth of Embryonic neural stem cells, Sci Rep 4:5103. doi.org/10.1038/srep05103
  24. De Theije CG, Wu J, da Silva SL, et al. (2011) Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management, Eur J Pharmacol 668(1):70-80. doi.org/10.1016/j.ejphar.2011.07.013
  25. Ding HT, Taur Y e Walkup JT (2017) Gut Microbiota and Autism: Key Concepts and Findings, J Autism Dev Disord 47:480-489. doi.org/10.1007/s10803-016-2960-9
  26. Editors of The Lancet (2010) Retraction--Ileal-lymphoid-nodular hyperplasia, non-specifi c colitis, and pervasive developmental disorder in children, Lancet 375(9713):445 . doi.org/10.1016/S0140-6736(10)60175-4
  27. Eskenazi B, Marks AR, Bradman A, et al. (2007) Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children, Environ Health Perspect 115:792-798. doi.org/10.1289/ehp.9828
  28. Fombonne E (2009) Epidemiology of pervasive developmental disorders, Pediatr Res 65:591-598. doi.org/10.1203/PDR.0b013e31819e7203
  29. Gillman MW, Barker D, Bier D, et al. (2007) Meeting report on the 3rd International Congress on Developmental Origins of Health and Disease (DOHaD), Pediatr Res 61(5 Pt 1):625-629. doi.org/10.1203/pdr.0b013e3180459fcd
  30. Gluckman PD e Hanson MA (2004) Developmental origins of disease paradigm: a mechanistic and evolutionary perspective, Pediatr Res 56:311-317. doi.org/10.1203/01.PDR.0000135998.08025.FB
  31. Grandjean P e Landrigan PJ (2006) Developmental neurotoxicity of industrial chemicals, Lancet 368:2167-2178. doi.org/10.1016/S0140-6736(06)69665-7
  32. Grandjean P e Landrigan PJ (2014) Neurobehavioural effects of developmental toxicity, Lancet Neurol 13(3):330-8. doi.org/10.1016/S1474-4422(13)70278-3
  33. Hertz-Picciotto I e Delwiche L (2009) The rise in autism and the role of age at diagnosis, Epidemiology 20(1):84-90. doi.org/10.1097/EDE.0b013e3181902d15
  34. Johansson C, Castoldi AF, Onishchenko N, et al. (2007) Neurobehavioural and molecular changes induced by methylmercury exposure during development, Neurotox Res 11:241-260. doi.org/10.1007/BF03033570
  35. Kanner L (1943) Autistic disturbances of affective contact, Nervous Child 2:217-250.
  36. Keil A, Daniels JL, Forssen U, et al. (2010) Parental autoimmune diseases associated with autism spectrum disorders in offspring, Epidemiology 21(6):805-808. doi.org/10.1097/EDE.0b013e3181f26e3f
  37. Lahiri DK, Maloney B, Basha MR, et al. (2007) How and when environmental agents and dietary factors affect the course of Alzheimer’s disease: the “LEARn” model (Latent Early Associated Regulation) may explain the triggering of AD, Curr Alzheimer Res 4:219-228. doi.org/10.2174/156720507780362164
  38. Landrigan PJ, Sonawane B, Butler RN, et al. (2005) Early environmental origins of neurodegenerative disease in later life, Environ Health Perspect 113:1230-1233. doi.org/10.1289/ehp.7571
  39. Lanphear BP, Hornung R, Khoury J, et al. (2005) Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis, Environ Health Perspect 113:894-899. doi.org/10.1289/ehp.7688
  40. Levy SE, Mandell DS e Schultz RT (2009) Autism, Lancet 374(9701):1627-1638. doi.org/10.1016/S0140-6736(09)61376-3
  41. McElhanon BO, McCracken C, Karpen S, et al. (2014) Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis, Pediatrics 133(5):872-883. doi.org/10.1542/peds.2013-3995
  42. Meyer U, Feldon J e Dammann O (2011) Schizophrenia and autism: both shared and disorder-specifi c pathogenesis via perinatal infl ammation?, Pediatr Res 69(5 Pt 2):26R-33R. doi.org/10.1203/PDR.0b013e318212c196
  43. Michell-Robinson MA, Touil H, Healy LM, et al. (2015) Roles of microglia in brain development, tissue maintenance and repair, Brain 138(Pt 5):1138-1159. doi.org/10.1093/brain/awv066
  44. Molloy CA, Morrow AL, Meinzen-Derr J, et al. (2006) Familial autoimmune thyroid disease as a risk factor for regression in children with autism spectrum disorder: A CPEA Study, J Autism Dev Disord 36(3):317-324. doi.org/10.1007/s10803-005-0071-0
  45. Morgan JT, Chana G, Abramson I, et al. (2012) Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism, Brain Res 1456:72-81. doi.org/10.1016/j.brainres.2012.03.036
  46. Onore C, Careaga M e Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism, Brain Behav Immun 26(3):383-392. doi.org/10.1016/j.bbi.2011.08.007
  47. Orihuela R, McPherson CA e Harry GJ (2015) Microglial M1/M2 polarization and metabolic states, Br J Pharmacol 173(4):649-665. doi.org/10.1111/bph.13139
  48. Rauh VA, Garfi nkel R, Perera FP, et al. (2006) Impact of prenatal chlorpyrifos exposure on neurodevelopment in the fi rst 3 years of life among inner-city children, Pediatrics 118(6):e1845-e1859. doi.org/10.1542/peds.2006-0338
  49. Rice D e Barone S Jr (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models, Environ Health Perspect 108(Suppl 3):511-533. doi.org/10.1289/ehp.00108s3511
  50. Roberts EM, English PB, Grether JK, et al. (2007) Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley, Environ Health Perspect 115:1482-1489. doi.org/10.1289/ehp.10168
  51. Sandler HS, Finegold SM, Bolte ER, et al. (2000) Short-Term Benefi t From Oral Vancomycin Treatment of Regressive-Onset Autism, J Child Neurology 15(7):429-435. doi.org/10.1177/088307380001500701
  52. Shelton JF, Hertz-Picciotto I e Pessah IN (2012) Tipping the Balance of Autism Risk: Potential Mechanisms Linking Pesticides and Autism, Environ Health Perspect 120(7):944-951. doi.org/10.1289/ehp.1104553
  53. Schwarz JM e Bilbo SD (2012) Sex, glia, and development: interactions in health and disease, Horm Behav 62:243-253. doi.org/10.1016/j.yhbeh.2012.02.018
  54. Singer, Morris C, Gause C, HS et al. (2009) Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model, J Neuroimmunol 211(1-2):39-48. doi.org/10.1016/j.jneuroim.2009.03.011
  55. Sweeten TL, Bowyer SL, Possey DJ, et al. (2003) Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders, Pediatrics 112(5):e420. doi.org/10.1542/peds.112.5.e420
  56. Tchaconas A e Adesman A (2013) Autism spectrum disorders: a pediatric overview and update, Curr Opin Pediatr 25:130-144. doi.org/10.1097/MOP.0b013e32835c2b70
  57. Vargas DL, Nascimbene C, Krishnan C, et al. (2005) Neuroglial activation and neuroinfl ammation in the brain of patients with autism, Ann Neurol 57(1):67-81. doi.org/10.1002/ana.20315
  58. Virtanen HE, Rajpert-De Meyts E, Main KM, et al. (2005) Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders, Toxicol Appl Pharmacol, 207(2 Suppl):501-505. doi.org/10.1016/j.taap.2005.01.058
  59. Wakefi eld AJ, Murch SH, Anthony A, et al. (1998) Ileal-lymphoid-nodular hyper-plasia, non-specifi c colitis, and pervasive developmental disorder in children, Lancet, 351(9103):637-641. doi.org/10.1016/S0140-6736(97)11096-0
  60. Whyatt RM, Barr DB, Camann DE, et al. (2003) Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns, Environ Health Perspect 111(5):749-756. doi.org/10.1289/ehp.5768
  61. Whyatt RM, Camann D, Perera FP, et al. (2005) Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth, Toxicol Appl Pharmacol 206(2):246-254. doi.org/10.1016/j.taap.2004.11.027
  62. Yang X, Wang X, Liu D, et al. (2014) Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b, Mol Endocrinol 28(4):565-574. doi.org/10.1210/me.2013-1293
  63. Zerbo O, Iosif AM, Walker C, et al. (2013) Is maternal infl uenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (Childhood Autism Risks from Genetics and Environment) study, J Autism Dev Disord 43(1):25-33. doi.org/10.1007/s10803-012-1540-x



  1. Cristina Panisi, Ernesto Burgio, Neurosviluppo e vaccini: dall'epigenetica alla clinica in PNEI REVIEW 1/2018 pp. 76, DOI: 10.3280/PNEI2018-001007

Ernesto Burgio, Cristina Panisi, in "PNEI REVIEW" 1/2017, pp. 17-32, DOI:10.3280/PNEI2017-001003

   

FrancoAngeli è membro della Publishers International Linking Association associazione indipendente e no profit per facilitare l'accesso degli studiosi ai contenuti digitali nelle pubblicazioni professionali e scientifiche